Overview

Apheresis Systems Market Introduction Apheresis Systems Market is envisioned to value over US $ 4 billion by the end of 2027 and record at a CAGR of over 7% during the forecast period of 2020-2027. Apheresis system is very helpful when it comes to collection and separation of blood components that are necessary for donation. Additionally, it also assists in removing or exchanging blood components for the purpose of therapy. The plasma or platelets are separated and collected when the red blood cells are returned back into the bloodstream of the donor. Depending on the blood constituents that undergo centrifugation, there are various types of procedures such as platelets (plateletphersis), plasma (plasmapheresis), lymphocytes (lymphophersis or lymphaphersis), leukocytes (leukaphersis) and red blood cells (erythrophersis). This procedure can also be implemented for

therapy where the diseased blood component is removed while the healthy blood component is returned back into the circulation of the patient. Additionally, this procedure can also be used for the purpose of stem cell harvesting. The increasing importance of apheresis systems in blood component separation in therapeutics procedure fuelled the growth of the market. It is commonly used for severe rheumatoid arthritis, Goodpasture syndrome, leukostasis, systemic lupus, and others. It is also used to reduce the risk of the antibody-mediated immune response during organ transplantation. So, it has significant importance in the healthcare setting in lifesaving interventions. It is further supported by the rapid advancement of technologies and led to the rapid evolution of continuous units for simultaneous blood collection and removal. Additionally, recent advancements decreased complications associated and made it more advantageous over the traditional methods. Further, increasing healthcare expenditure by both private and public sectors to incorporate advanced technologies created huge opportunities for the market growth The Asia Pacific account significant share in the global market and created potential opportunities for international players due to increasing government support. It is majorly dominated by domestic manufacturers and expected to remain the same throughout the forecast period. Whereas, developed economies like North America & Europe witnessed strong penetration due to the increasing prevalence and stringent regulatory conditions. US, UK, France, Japan, and Germany account a major share in the global market due to high penetration. Latin America and Rest of World regions witnessed fast growth rate during the forecast period due to increasing adoption. Major market players include

TERUMO BCT, INC., Fresenius Kabi, B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd, Macopharma, Grifolss, Delcon Medical Devices, and others. Apheresis Systems Market Segmentation: By Product Type Standalone Apheresis Systems

Portable Apheresis Systems

Consumables and Supplies By End User Hospitals

Outpatient Centres

Blood Banks By Region North America

Latin America

Europe

Asia Pacific

Rest of the World Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share

• Tier 2 players

• Emerging players which are growing rapidly

• New Entrants FutureWise Key Takeaways

• Growth prospects

• SWOT analysis

• Key trends

• Key data-points affecting market growth Objectives of the Study:

• To provide with an exhaustive analysis on the global Apheresis Systems Market by Product Type, by End User, by Region

• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

• To evaluate and forecast micro-markets and the overall market

• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East

• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

• Profiling of companies to evaluate their market shares, strategies, financials and core competencies